Medicines and Judicial Appointment




NEW ZEALAND GAZETTE, No. 88 — 31 AUGUST 2017

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Children’s Claratyne
Loratadine 5mg
Chewable tablet
Bayer New Zealand Limited
Pantheon Manufacturing Services LLC, North Carolina, United States of America

Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Entop Plus
Lidocaine hydrochloride 50mg/mL
Phenylephrine hydrochloride 5mg/mL
Nasal spray solution
Flo Pharmaceuticals Limited
Mayne Pharma International Pty Limited, Adelaide, Australia

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Ketamine Mylan
Ketamine hydrochloride 115.3mg/mL equivalent to ketamine 100mg/mL
Solution for injection
Mylan New Zealand Limited
Mylan Teoranta Limited, Galway, Ireland

Dated this 25th day of August 2017.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

2017-go4492

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Cathejell Lignocaine 2% gel
Lidocaine hydrochloride monohydrate 2.133%w/w equivalent to lidocaine hydrochloride anhydrous 2%w/w
Topical gel
InterPharma (NZ) Limited
Pharm. Fabrik Montavit Ges.m.b.H, Absam, Austria

Note: This consent is given subject to the following conditions:

  • Provisional consent is given subject to the following restriction: The medicine may only be marketed or distributed when no other lignocaine hydrochloride 2% gel with consent to distribute for urethral use is available in the New Zealand market.

Also note: This consent is valid for one year from the date of publication of this notice.

Dated this 25th day of August 2017.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

2017-go4493

Acting Employment Court Judge Appointed

Pursuant to section 207 of the Employment Relations Act 2000, Her Excellency the Governor-General of New Zealand has been pleased to appoint

Richard John McIlraith, District Court Judge

to be an acting Judge of the Employment Court for a term of two years commencing on 21 August 2017.

Dated at Wellington this 21st day of August 2017.

HON CHRISTOPHER FINLAYSON, QC, Attorney-General.

49



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2017, No 88





✨ LLM interpretation of page content

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
25 August 2017
Medicines Act, New Medicines, Children’s Claratyne, Entop Plus, Ketamine Mylan, Bayer New Zealand Limited, Flo Pharmaceuticals Limited, Mylan New Zealand Limited
  • CHRIS JAMES, Group Manager, Medsafe, Ministry of Health

🏥 Provisional Consent to the Distribution of a New Medicine

🏥 Health & Social Welfare
25 August 2017
Medicines Act, Provisional Consent, Cathejell Lignocaine 2% gel, InterPharma (NZ) Limited
  • CHRIS JAMES, Group Manager, Medsafe, Ministry of Health

⚖️ Acting Employment Court Judge Appointed

⚖️ Justice & Law Enforcement
21 August 2017
Employment Relations Act, Acting Judge, Employment Court, Richard John McIlraith
  • Richard John McIlraith (District Court Judge), Appointed acting Judge of the Employment Court

  • HON CHRISTOPHER FINLAYSON, QC, Attorney-General